Ying Gu
23Patents
2h-index
48Co-inventors
53Inventor score
Filing activity: Sep 30, 2001 → Oct 11, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9512185B2 | Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof | Chemistry; Metallurgy | 2 | Active |
| US7786264B2 | Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof | Chemistry; Metallurgy | 2 | Expired |
| US11154548B2 | Monosubstituted or polysubstituted amphiphilic hypocrellin derivative, and preparation method and application thereof | Chemistry; Metallurgy | 1 | Active |
| US7615228B2 | Polypeptide fragments of hepatitis E virus, the vaccine comprising said fragments and the diagnostic kits | Chemistry; Metallurgy | 1 | Expired |
| US8524868B2 | Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits | Chemistry; Metallurgy | 0 | Active |
| US9192638B2 | Preparation comprising amino acids and plants and its activity in the alcohol detoxification | Human Necessities | 0 | Active |
| US9764028B2 | Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof | Chemistry; Metallurgy | 0 | Active |
| US10940194B2 | Mutant of L1 protein of human papillomavirus type 58 | Chemistry; Metallurgy | 0 | Active |
| US8715695B2 | Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits | Chemistry; Metallurgy | 0 | Active |
| US10537629B2 | Truncated L1 protein of human papillomavirus type 11 | Chemistry; Metallurgy | 0 | Active |
| US11585816B2 | Automated method for assessing cancer risk using tissue samples, and system therefor | Physics | 0 | Active |
| US9428555B2 | Truncated L1 protein of Human Papillomavirus type 16 | Chemistry; Metallurgy | 0 | Active |
| US12097251B2 | Human papilloma virus type 51 L1 protein mutants | Chemistry; Metallurgy | 0 | Active |
| US9526753B2 | Preparation comprising amino acids and plants and its activity in the alcohol detoxification | Human Necessities | 0 | Active |
| US9428554B2 | Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof | Chemistry; Metallurgy | 0 | Active |
| US9533035B2 | Truncated L1 protein of human papillomavirus type 11 | Chemistry; Metallurgy | 0 | Active |
| US11475515B1 | Adverse action methodology for credit risk models | Physics | 0 | Active |
| US12018078B2 | SEMA4D antibody, preparation method therefor and use thereof | Physics | 0 | Active |
| US11771754B2 | Mutant of L1 protein of human papillomavirus type 18 | Chemistry; Metallurgy | 0 | Active |
| US11213580B2 | Mutant of L1 protein of human papillomavirus type 16 | Chemistry; Metallurgy | 0 | Active |
| US11439707B2 | Hypocrellin derivative substituted both in a peri-position and in 2-position by amino, preparation method, and application thereof | Chemistry; Metallurgy | 0 | Active |
| US9943586B2 | Truncated L1 protein of human papillomavirus type 11 | Chemistry; Metallurgy | 0 | Active |
| US9757450B2 | Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.